| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/08/1997 | EP0751784A1 Thyroxin-binding proteins |
| 01/08/1997 | EP0751770A1 8-substituted tetrahydro-beta-carbolines |
| 01/08/1997 | EP0751769A1 Medical treatment using thyroid hormones |
| 01/08/1997 | EP0751767A1 Therapeutic guanidines |
| 01/08/1997 | EP0751766A1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | EP0568577B1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139931A Cyclic neurokinin a antagonists |
| 01/08/1997 | CN1139928A Novel compound |
| 01/08/1997 | CN1139927A Substituted morpholine derivatives and their use as therapeutic agents |
| 01/08/1997 | CN1139666A Novel tricyclic amide, its preparation method and medicinal combination |
| 01/08/1997 | CN1139558A Detoxifying combination for cigarette preparation method and pharmaceutics |
| 01/08/1997 | CN1139552A Bear bile products and preparation process |
| 01/07/1997 | US5591866 Neuroprotective agents |
| 01/07/1997 | US5591856 Chemical intermediates, treatment of alzheimer's disease |
| 01/07/1997 | US5591775 Sleep disorders |
| 01/07/1997 | US5591757 Dihydropyridine composition |
| 01/07/1997 | US5591755 Pyridinyl thiadiazolyl compounds for treating glaucoma |
| 01/07/1997 | US5591746 Glutamate inhibitors; central nervous system disorders |
| 01/07/1997 | US5591745 (4-heteroaryl)-1-[(2,3-dihydro-1H-isoindol-2-yl)alkyl] piperidines and related compounds and their therapeutic utility |
| 01/07/1997 | US5591743 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands |
| 01/07/1997 | US5591733 Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/07/1997 | US5591732 Administering 4-chloro-1-dehydromethyltestosterone and/or mestanolone to treat osteoporosis |
| 01/07/1997 | US5591721 Orally administering oligonucleotide with phosphorothioate internucleoside linkage |
| 01/07/1997 | US5591629 Monoclonal antibodies which promote central nervous system remyelination |
| 01/07/1997 | US5591452 Controlled release formulation |
| 01/07/1997 | CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/07/1997 | CA2005919C N-substituted azaheterocyclic carboxylic acids |
| 01/03/1997 | WO1997000243A1 5-aminoalkyl-2-(2-alkoxyphenyl)-pyrrole derivatives having affinity for dopamine d3 receptors and their use in the treatment of psychoses |
| 01/03/1997 | WO1997000074A1 USE OF IMIDAZO[1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS |
| 01/03/1997 | WO1997000063A2 Urocortin peptides |
| 01/03/1997 | CA2223792A1 Urocortin peptides |
| 01/02/1997 | EP0751129A1 Substituted dihydrodibenzo/b, f/azepines, method for their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
| 01/02/1997 | EP0750909A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
| 01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750621A1 Heterocyclic compounds, their preparation and use |
| 01/02/1997 | EP0750616A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| 01/02/1997 | EP0750608A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
| 01/02/1997 | EP0750607A1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity |
| 01/02/1997 | EP0750509A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/01/1997 | CN1139434A Diazabicyclic neurokinin antagonists |
| 01/01/1997 | CN1139431A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders |
| 01/01/1997 | CN1139111A Novel pyridine compounds, processes for their preparation and pharmaceutical compositions which contain them |
| 01/01/1997 | CN1139110A Inhibitng photodecomposition of 3-substituted-2-oxindoles |
| 01/01/1997 | CN1139108A Substituted benzothienylpiperazines their use as medicaments, and processes for their preparation |
| 12/31/1996 | US5589514 Arylcycloalkyl derivatives, their production and their use |
| 12/31/1996 | US5589513 Pharmaceutical composition and process for the preparation thereof |
| 12/31/1996 | US5589501 Pharmaceutical compounds |
| 12/31/1996 | US5589495 2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3- indandiones and related compounds and their therapeutic utility |
| 12/31/1996 | US5589494 2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3-dioxanes and related compounds and their therapeutic utility |
| 12/31/1996 | US5589488 Antipsychotic agents, analgesics |
| 12/31/1996 | US5589486 N-hydroxyalkyl-substituted 1,2,3,6-tetrahydro-pyridine and piperidine derivatives |
| 12/31/1996 | US5589475 Benzodiazepine treatment |
| 12/31/1996 | US5589467 2,5',N6-trisubstituted adenosine derivatives |
| 12/31/1996 | US5589460 Modification of melanotrophic release inhibiting factor |
| 12/31/1996 | US5589458 Compounds that inhibit T cell proliferation and methods for using the same |
| 12/31/1996 | US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia |
| 12/31/1996 | US5589192 Gel pharmaceutical formulation for local anesthesia |
| 12/31/1996 | US5589156 Prilocaine and hydrofluourocarbon aerosol preparations |
| 12/31/1996 | US5589154 Diagnosing presence of b-amyloid peptide |
| 12/31/1996 | CA2054752C Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
| 12/27/1996 | WO1996041796A1 Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041630A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | WO1996041616A1 Formulations and methods for providing prolonged local anesthesia |
| 12/27/1996 | WO1996041609A2 Methods and compositions for stimulating neurite growth |
| 12/27/1996 | WO1996037226A3 Combinations for the treatment of parkinsonism containing selective nmda antagonists |
| 12/27/1996 | EP0749981A1 Monoclonal antibody |
| 12/27/1996 | EP0749970A1 Benzisothiazolyl-substituted aminomethylchroman derivatives |
| 12/27/1996 | EP0749422A1 Indole derivatives as cck receptor antagonists |
| 12/27/1996 | EP0749417A1 Cyano compounds and preparations thereof |
| 12/27/1996 | EP0680326B1 Pharmaceutical composition for treating nicotine dependence |
| 12/27/1996 | EP0572635B1 Compounds having a guanidine structure and pharmaceutical compositions containing same |
| 12/27/1996 | EP0500853B1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | CA2222430A1 Methods and compositions for stimulating neurite growth |
| 12/27/1996 | CA2222225A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system |
| 12/25/1996 | CN1138853A 1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists |
| 12/25/1996 | CN1138465A Medicine for treatment of epilepsy |
| 12/25/1996 | CN1033641C Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-Yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride |
| 12/24/1996 | US5587479 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 12/24/1996 | US5587398 Affinity for serotonergic neurons; treating nervous system disorder; lipophilic |
| 12/24/1996 | US5587380 Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines which are pharmacologically active CNS compounds |
| 12/24/1996 | US5587376 Antiischemic agents, decongestants |
| 12/24/1996 | US5587363 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 12/24/1996 | CA1338808C Cyclic amine compound |
| 12/20/1996 | CA2179205A1 Benzisothiazolyl-substituted aminomethylchromans |